Graf Susan E

CIK 00015776375 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001577637

Recent Transactions

28 trades

Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-06-04+9,354→ 9,354 total
Award
Aardvark Therapeutics, Inc.$AARD
Stock Option (right to buy)
2025-06-11+30,508→ 30,508 total
Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-06-05+24,165→ 24,165 total
Award
CG Oncology, Inc.$CGON
Stock Option (Right to Buy)
2024-10-04+15,600→ 15,600 total
Purchase
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2023-06-09$0.27/sh+5,010→ 5,010 total
Award
Finch Therapeutics Group, Inc.$FNCH
Stock Option (right to buy)
2023-06-08+10,000→ 10,000 total
Award
Finch Therapeutics Group, Inc.$FNCH
Stock Option (right to buy)
2022-06-13+44,843→ 44,843 total
Award
Finch Therapeutics Group, Inc.$FNCH
Stock Option (right to buy)
2021-04-23+23,419→ 23,419 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2018-02-09+106,344→ 106,344 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2017-02-08+109,866→ 109,866 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2016-04-25+178,642→ 178,642 total
Disposition from Tender
NPS PHARMACEUTICALS INC
Common Stock
2015-02-21$46.00/sh−4,761→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Stock Options (right to buy)
2015-02-21−41,289→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-21−2,893→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-21−10,905→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-21−11,577→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Stock Options (right to buy)
2015-02-21−11,874→ 0 total
Exercise/Conversion
NPS PHARMACEUTICALS INC
Common Stock
2015-02-12+1,445→ 5,245 total
Award
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-12+10,905→ 10,905 total
Exercise/Conversion
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-12−1,445→ 2,893 total
Tax Payment
NPS PHARMACEUTICALS INC
Common Stock
2015-02-12$45.85/sh−484→ 4,761 total
Exercise/Conversion
NPS PHARMACEUTICALS INC
Common Stock
2015-02-10$14.90/sh+6,711→ 10,511 total
Exercise/Conversion
NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
2015-02-10−6,711→ 41,289 total
Sale
NPS PHARMACEUTICALS INC
Common Stock
2015-02-10$45.87/sh−6,711→ 3,800 total
Award
NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
2014-02-12+11,874→ 11,874 total
Award
NPS PHARMACEUTICALS INC
Restricted Stock Units
2014-02-12+4,338→ 4,338 total
Award
NPS PHARMACEUTICALS INC
Restricted Stock Units
2013-06-17+17,365→ 17,365 total
Award
NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
2013-06-17+48,000→ 48,000 total

Companies

Recent Filings

Address

C/O CG ONCOLOGY, INC. 3000 PEGASUS PARK DRIVE, SUITE 1640

DALLAS, TX, 75247

View on SEC.gov